NCT01975051View on ClinicalTrials.gov

A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Post-kala-azar Dermal Leishmaniasis
Interventions
DRUG

Mitefosine

Tablet Miltefosine 100 mg in two devided doses for 12 weeks

Trial Locations (1)

1212

Dinesh Mondal, Dhaka

All Listed Sponsors
collaborator

University of Nagasaki.

UNKNOWN

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT01975051 - A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) | Biotech Hunter | Biotech Hunter